Every year on July 1, the Régie de l’assurance maladie du Québec (RAMQ) adjusts the rates for the public prescription drug insurance plan to take into account the increase or decrease in plan costs.

In our bulletin from July, we explained that the financial pressures caused by the COVID-19 situation in Quebec had prompted the RAMQ to set rates below what was expected based on the evolution of the plan’s costs. At the time, the RAMQ reserved the right to review rates as of January 1, 2021, rather than wait until July 1, 2021, as expected.

On December 16, 2020, the regulations under Bill 31 were given assent. As a result, the removal of the cost of several pharmaceutical services will improve access to them and help to continue expanding the role of pharmacists as front-line professionals. These amendments take effect on January 25.

On this page, you will find all the articles, documents and events that will help you understanding total rewards in the context of the COVID-19 pandemic.

Any questions? Contact us!